Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pautier

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancerV Boige, E Raymond, S Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapyP Morice, C Deyrolle, A Rey, et al.
Gynecologie, Obstetrique & Fertilite|June 26, 2004
[Are nodal metastases in ovarian cancer chemoresistant lesions? Comparative study of initial lymphadenectomy or after chemotherapy]F Joulie, P Morice, A Rey, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2004
Prognosis of stage III or IV primary peritoneal serous papillary carcinomaG Dubernard, P Morice, A Rey, et al.
Gynecologie, Obstetrique & Fertilite|November 27, 2002
[Results and fertility after conservative treatment of invasive epithelial ovarian cancer]P Morice, F Wicart-Poque, A Rey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2004
Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy aloneP Pautier, A Rey, C Haie-Meder, et al.
Bulletin Du Cancer|March 13, 2002
[What hysterectomy procedure should be carried out for cancer of the endometrium in stage I-II]Philippe Morice, S Camatte, Eric Fondrinier, et al.
Bulletin Du Cancer|February 1, 1997
[Negative second-look laparatomy in ovarian cancers. Survival analysis and prognostic factors from 64 cases treated at the Gustave Roussy Institute]P Pautier, A Rey, G Michel, et al.
Leukemia & Lymphoma|February 27, 1999
Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literatureP Pautier, A Devidas, A Delmer, et al.
Gynecologic Oncology|September 24, 2009
Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II studyF Joly, T Petit, P Pautier, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Phase I and pharmacokinetic study of the camptothecin analog DX-8951f administered as a 30-minute infusion every 3 weeks in patients with advanced cancerV Boige, E Raymond, S Faivre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Value of routine follow-up procedures for patients with stage I/II cervical cancer treated with combined surgery-radiation therapyP Morice, C Deyrolle, A Rey, et al.
Gynecologie, Obstetrique & Fertilite|June 26, 2004
[Are nodal metastases in ovarian cancer chemoresistant lesions? Comparative study of initial lymphadenectomy or after chemotherapy]F Joulie, P Morice, A Rey, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2004
Prognosis of stage III or IV primary peritoneal serous papillary carcinomaG Dubernard, P Morice, A Rey, et al.
Gynecologie, Obstetrique & Fertilite|November 27, 2002
[Results and fertility after conservative treatment of invasive epithelial ovarian cancer]P Morice, F Wicart-Poque, A Rey, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2004
Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy aloneP Pautier, A Rey, C Haie-Meder, et al.
Bulletin Du Cancer|March 13, 2002
[What hysterectomy procedure should be carried out for cancer of the endometrium in stage I-II]Philippe Morice, S Camatte, Eric Fondrinier, et al.
Bulletin Du Cancer|February 1, 1997
[Negative second-look laparatomy in ovarian cancers. Survival analysis and prognostic factors from 64 cases treated at the Gustave Roussy Institute]P Pautier, A Rey, G Michel, et al.
Leukemia & Lymphoma|February 27, 1999
Angioimmunoblastic-like T-cell non Hodgkin's lymphoma: outcome after chemotherapy in 33 patients and review of the literatureP Pautier, A Devidas, A Delmer, et al.
Gynecologic Oncology|September 24, 2009
Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: a French multicenter phase II studyF Joly, T Petit, P Pautier, et al.
Pageof 15